# Inhibrx Biosciences, Inc.: Form DEF 14A, filed Apr 16, 2025

- Company: [Inhibrx Biosciences, Inc.](/companies/inbx.md) (CIK 2007919)
- Form: DEF 14A
- Filed: 2025-04-16
- Accepted by EDGAR: Apr 16, 2025, 16:49 ET
- Period: 2024-12-31
- Accession: 0002007919-25-000043
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2007919/000200791925000043/inbx-20250416.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2007919/000200791925000043/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2007919/000200791925000043/inbx-20250416.htm

Filed Apr 16, 2025.
Source: SEC EDGAR, the filing index for accession 0002007919-25-000043. Last ingested by Listed: Nov 14, 2026, 21:07 ET. No prices; not investment advice.
